Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leiomyoma | 49 | 2024 | 663 | 7.710 |
Why?
|
Uterine Neoplasms | 52 | 2024 | 1444 | 5.840 |
Why?
|
Chromosome Aberrations | 53 | 2024 | 1767 | 5.370 |
Why?
|
Translocation, Genetic | 59 | 2023 | 1386 | 4.650 |
Why?
|
Gene Rearrangement | 19 | 2021 | 1116 | 2.910 |
Why?
|
Chromosome Disorders | 16 | 2021 | 499 | 2.760 |
Why?
|
Deafness | 25 | 2022 | 457 | 2.570 |
Why?
|
Hearing Loss | 20 | 2022 | 777 | 2.440 |
Why?
|
Karyotyping | 69 | 2019 | 1181 | 2.190 |
Why?
|
Chromosome Mapping | 102 | 2021 | 4627 | 2.020 |
Why?
|
Leiomyomatosis | 8 | 2016 | 69 | 2.010 |
Why?
|
Hearing Loss, Sensorineural | 23 | 2019 | 783 | 1.930 |
Why?
|
Chromosomal Position Effects | 3 | 2018 | 12 | 1.830 |
Why?
|
In Situ Hybridization, Fluorescence | 71 | 2017 | 2497 | 1.810 |
Why?
|
Cochlea | 25 | 2022 | 841 | 1.790 |
Why?
|
Chromosomes, Human | 6 | 2020 | 444 | 1.780 |
Why?
|
HMGA2 Protein | 11 | 2012 | 103 | 1.760 |
Why?
|
Genetics, Medical | 7 | 2021 | 336 | 1.700 |
Why?
|
Genome, Human | 19 | 2024 | 4391 | 1.680 |
Why?
|
Chromosome Breakpoints | 6 | 2020 | 93 | 1.680 |
Why?
|
Oligospermia | 2 | 2023 | 59 | 1.570 |
Why?
|
Cytogenetic Analysis | 15 | 2021 | 271 | 1.570 |
Why?
|
Chromosomes, Human, Pair 5 | 13 | 2016 | 385 | 1.440 |
Why?
|
Chromosomes, Human, Pair 12 | 16 | 2012 | 430 | 1.390 |
Why?
|
Abnormalities, Multiple | 10 | 2020 | 1417 | 1.360 |
Why?
|
Vestibular Diseases | 8 | 2014 | 229 | 1.300 |
Why?
|
Prenatal Diagnosis | 9 | 2020 | 1270 | 1.300 |
Why?
|
Extracellular Matrix Proteins | 26 | 2019 | 828 | 1.280 |
Why?
|
Congenital Abnormalities | 6 | 2019 | 704 | 1.280 |
Why?
|
Chromosome Deletion | 21 | 2021 | 1387 | 1.230 |
Why?
|
Chromosomes, Human, Pair 7 | 18 | 2010 | 311 | 1.190 |
Why?
|
Hearing | 8 | 2021 | 497 | 1.140 |
Why?
|
Chromosome Inversion | 9 | 2017 | 118 | 1.070 |
Why?
|
Nucleotides | 2 | 2020 | 453 | 1.070 |
Why?
|
Phenotype | 34 | 2024 | 16442 | 1.050 |
Why?
|
Proteins | 27 | 2024 | 6026 | 1.040 |
Why?
|
Abortion, Habitual | 2 | 2023 | 62 | 1.030 |
Why?
|
Genetic Predisposition to Disease | 33 | 2024 | 17684 | 0.980 |
Why?
|
High Mobility Group Proteins | 8 | 2002 | 175 | 0.910 |
Why?
|
Chromosomes, Human, Pair 2 | 12 | 2012 | 313 | 0.880 |
Why?
|
Myometrium | 6 | 2012 | 176 | 0.850 |
Why?
|
Genome-Wide Association Study | 15 | 2024 | 12482 | 0.830 |
Why?
|
Chromosomes, Human, Pair 1 | 14 | 2016 | 637 | 0.820 |
Why?
|
Developmental Disabilities | 6 | 2018 | 1501 | 0.810 |
Why?
|
Chromosomes, Human, Pair 14 | 13 | 2005 | 287 | 0.790 |
Why?
|
Neonatal Screening | 7 | 2021 | 594 | 0.740 |
Why?
|
Smooth Muscle Tumor | 2 | 2016 | 63 | 0.740 |
Why?
|
Genetic Testing | 11 | 2021 | 3506 | 0.730 |
Why?
|
Infertility, Male | 2 | 2022 | 395 | 0.710 |
Why?
|
Chromosome Banding | 28 | 2016 | 261 | 0.700 |
Why?
|
Chromosomes, Human, Pair 9 | 9 | 2008 | 534 | 0.700 |
Why?
|
Frameshift Mutation | 4 | 2019 | 387 | 0.700 |
Why?
|
Tooth Abnormalities | 1 | 2020 | 56 | 0.690 |
Why?
|
Facies | 2 | 2020 | 198 | 0.680 |
Why?
|
Genes, Dominant | 5 | 2020 | 864 | 0.680 |
Why?
|
Genetic Linkage | 26 | 2012 | 2383 | 0.680 |
Why?
|
Trisomy | 11 | 2004 | 260 | 0.680 |
Why?
|
Leiomyosarcoma | 6 | 2008 | 426 | 0.670 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2019 | 3772 | 0.660 |
Why?
|
Bone Diseases, Developmental | 2 | 2020 | 127 | 0.660 |
Why?
|
Genes | 24 | 2002 | 1845 | 0.650 |
Why?
|
Base Sequence | 69 | 2021 | 12439 | 0.650 |
Why?
|
Serine Proteases | 1 | 2018 | 50 | 0.630 |
Why?
|
Lipoma | 6 | 2004 | 292 | 0.630 |
Why?
|
Polymerase Chain Reaction | 18 | 2020 | 6067 | 0.600 |
Why?
|
Humans | 342 | 2024 | 756111 | 0.600 |
Why?
|
Mediator Complex | 1 | 2018 | 106 | 0.590 |
Why?
|
Molecular Sequence Data | 79 | 2014 | 17607 | 0.580 |
Why?
|
Chromosome Breakage | 8 | 2012 | 159 | 0.570 |
Why?
|
Genomics | 11 | 2024 | 5742 | 0.560 |
Why?
|
Speech | 1 | 2021 | 550 | 0.550 |
Why?
|
DNA-Binding Proteins | 16 | 2019 | 9561 | 0.540 |
Why?
|
Expressed Sequence Tags | 7 | 2007 | 251 | 0.540 |
Why?
|
Gene Expression Profiling | 13 | 2018 | 9341 | 0.530 |
Why?
|
Ear, Inner | 9 | 2016 | 423 | 0.520 |
Why?
|
Hearing Disorders | 5 | 2019 | 128 | 0.520 |
Why?
|
Vascular Neoplasms | 2 | 2016 | 167 | 0.510 |
Why?
|
Alleles | 11 | 2017 | 6886 | 0.500 |
Why?
|
Gene Library | 8 | 2017 | 1059 | 0.490 |
Why?
|
Societies, Scientific | 2 | 2015 | 220 | 0.490 |
Why?
|
Hysterectomy | 5 | 2023 | 902 | 0.490 |
Why?
|
X Chromosome | 7 | 2013 | 812 | 0.480 |
Why?
|
Haploinsufficiency | 3 | 2013 | 327 | 0.480 |
Why?
|
Mutation | 45 | 2021 | 29764 | 0.480 |
Why?
|
Female | 166 | 2024 | 388229 | 0.470 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2020 | 3603 | 0.470 |
Why?
|
Mosaicism | 6 | 2009 | 457 | 0.460 |
Why?
|
Hearing Tests | 4 | 2021 | 122 | 0.450 |
Why?
|
Pedigree | 28 | 2021 | 4565 | 0.440 |
Why?
|
Chromosome Painting | 3 | 2001 | 26 | 0.440 |
Why?
|
Genomic Library | 2 | 2012 | 189 | 0.430 |
Why?
|
CHARGE Syndrome | 1 | 2012 | 30 | 0.420 |
Why?
|
Receptors, Estrogen | 3 | 2022 | 2187 | 0.420 |
Why?
|
Comparative Genomic Hybridization | 6 | 2023 | 472 | 0.420 |
Why?
|
Sequence Analysis, DNA | 25 | 2017 | 4703 | 0.420 |
Why?
|
Chromosomes, Human, Pair 8 | 8 | 2020 | 452 | 0.420 |
Why?
|
Uterine Artery Embolization | 2 | 2023 | 63 | 0.410 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2017 | 8438 | 0.410 |
Why?
|
Genetic Heterogeneity | 3 | 2012 | 719 | 0.400 |
Why?
|
Ear, Middle | 1 | 2014 | 336 | 0.400 |
Why?
|
Chromosomes, Human, Pair 6 | 9 | 2001 | 376 | 0.380 |
Why?
|
Endometriosis | 1 | 2019 | 869 | 0.380 |
Why?
|
Hearing Loss, Bilateral | 2 | 2009 | 53 | 0.370 |
Why?
|
Nucleic Acid Hybridization | 31 | 2004 | 1305 | 0.360 |
Why?
|
Gene Deletion | 8 | 2011 | 2667 | 0.360 |
Why?
|
RNA, Messenger | 31 | 2024 | 12755 | 0.360 |
Why?
|
Siblings | 3 | 2012 | 825 | 0.360 |
Why?
|
DNA Primers | 11 | 2020 | 2810 | 0.360 |
Why?
|
Cleft Palate | 7 | 2016 | 586 | 0.350 |
Why?
|
Amino Acid Sequence | 46 | 2017 | 13425 | 0.350 |
Why?
|
Gene Expression Regulation, Developmental | 11 | 2011 | 3594 | 0.350 |
Why?
|
Vestibule, Labyrinth | 2 | 2010 | 232 | 0.350 |
Why?
|
Histone Demethylases | 1 | 2013 | 322 | 0.350 |
Why?
|
DNA, Complementary | 18 | 2007 | 1991 | 0.350 |
Why?
|
Congresses as Topic | 1 | 2015 | 797 | 0.350 |
Why?
|
Fetus | 10 | 2006 | 1887 | 0.340 |
Why?
|
Publishing | 2 | 2015 | 835 | 0.340 |
Why?
|
COUP Transcription Factor I | 1 | 2009 | 12 | 0.340 |
Why?
|
Sequence Deletion | 3 | 2013 | 1494 | 0.340 |
Why?
|
Mutation, Missense | 8 | 2014 | 2554 | 0.340 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2008 | 1585 | 0.340 |
Why?
|
Chromosomes, Human, Pair 11 | 8 | 2014 | 410 | 0.330 |
Why?
|
Cytogenetics | 4 | 2016 | 198 | 0.330 |
Why?
|
Fetal Growth Retardation | 3 | 2006 | 570 | 0.330 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 15 | 2011 | 4569 | 0.320 |
Why?
|
Peritoneal Neoplasms | 2 | 2010 | 702 | 0.320 |
Why?
|
Blotting, Northern | 11 | 2006 | 1544 | 0.320 |
Why?
|
Software | 3 | 2022 | 4406 | 0.320 |
Why?
|
Chromosomes, Human, Pair 20 | 4 | 2017 | 127 | 0.310 |
Why?
|
Computational Biology | 5 | 2022 | 3486 | 0.310 |
Why?
|
Mice | 74 | 2024 | 80709 | 0.310 |
Why?
|
Physical Chromosome Mapping | 4 | 2002 | 182 | 0.310 |
Why?
|
Cell Cycle Proteins | 2 | 2019 | 3439 | 0.310 |
Why?
|
Fumarate Hydratase | 2 | 2007 | 52 | 0.310 |
Why?
|
Immunohistochemistry | 14 | 2012 | 11025 | 0.300 |
Why?
|
Gene Expression | 20 | 2019 | 7582 | 0.300 |
Why?
|
Animals | 104 | 2024 | 167069 | 0.300 |
Why?
|
Kallmann Syndrome | 3 | 2023 | 139 | 0.300 |
Why?
|
Transcription, Genetic | 15 | 2012 | 7574 | 0.290 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2007 | 28 | 0.290 |
Why?
|
Chromosomes, Human, Pair 3 | 6 | 2007 | 313 | 0.290 |
Why?
|
Diacylglycerol Kinase | 1 | 2007 | 48 | 0.290 |
Why?
|
Adult | 70 | 2024 | 218302 | 0.280 |
Why?
|
Chromosomes, Human, Pair 10 | 8 | 2007 | 276 | 0.280 |
Why?
|
Human Development | 1 | 2008 | 123 | 0.280 |
Why?
|
Chromosomes, Human, 6-12 and X | 8 | 2000 | 77 | 0.280 |
Why?
|
In Situ Hybridization | 13 | 2011 | 1897 | 0.280 |
Why?
|
Chromosomes, Human, Pair 17 | 9 | 2004 | 419 | 0.280 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 223 | 0.280 |
Why?
|
Terminology as Topic | 1 | 2014 | 1533 | 0.280 |
Why?
|
Chromosomes, Human, Pair 22 | 3 | 2023 | 345 | 0.280 |
Why?
|
Keratosis | 1 | 2006 | 80 | 0.270 |
Why?
|
Male | 113 | 2024 | 356852 | 0.270 |
Why?
|
Collagen Type IX | 1 | 2006 | 20 | 0.270 |
Why?
|
Photosensitivity Disorders | 1 | 2006 | 80 | 0.270 |
Why?
|
Research Design | 2 | 2021 | 6143 | 0.270 |
Why?
|
Genetic Variation | 7 | 2021 | 6506 | 0.270 |
Why?
|
Chromosomes, Human, Pair 21 | 3 | 2005 | 229 | 0.270 |
Why?
|
Postural Balance | 1 | 2010 | 613 | 0.260 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2006 | 99 | 0.260 |
Why?
|
Chromatin | 1 | 2018 | 2926 | 0.260 |
Why?
|
Decidua | 1 | 2006 | 82 | 0.260 |
Why?
|
Gene Frequency | 5 | 2021 | 3588 | 0.260 |
Why?
|
Multigene Family | 10 | 2016 | 1077 | 0.260 |
Why?
|
DNA | 29 | 2020 | 7222 | 0.260 |
Why?
|
Introns | 9 | 2004 | 974 | 0.260 |
Why?
|
Gene Amplification | 6 | 2002 | 1081 | 0.260 |
Why?
|
Janus Kinase 2 | 1 | 2008 | 530 | 0.250 |
Why?
|
Leadership | 1 | 2015 | 1362 | 0.250 |
Why?
|
GTP-Binding Proteins | 4 | 1998 | 947 | 0.250 |
Why?
|
Response Elements | 2 | 2020 | 307 | 0.250 |
Why?
|
Cochlear Diseases | 2 | 2020 | 23 | 0.250 |
Why?
|
Fetal Proteins | 2 | 1995 | 96 | 0.240 |
Why?
|
Infant, Newborn | 18 | 2021 | 26034 | 0.240 |
Why?
|
Syndrome | 16 | 2016 | 3272 | 0.240 |
Why?
|
Nose | 2 | 2019 | 515 | 0.240 |
Why?
|
Polymorphism, Single Nucleotide | 11 | 2024 | 15669 | 0.240 |
Why?
|
Trophoblasts | 1 | 2006 | 223 | 0.240 |
Why?
|
Germ-Line Mutation | 4 | 2024 | 1826 | 0.230 |
Why?
|
DNA Mutational Analysis | 14 | 2018 | 4111 | 0.230 |
Why?
|
3' Untranslated Regions | 1 | 2006 | 521 | 0.230 |
Why?
|
Ear | 2 | 2006 | 172 | 0.220 |
Why?
|
Collagen Type II | 2 | 2014 | 149 | 0.220 |
Why?
|
Chromosomes | 5 | 2019 | 576 | 0.220 |
Why?
|
Periodicals as Topic | 1 | 2015 | 1456 | 0.220 |
Why?
|
Collagen | 4 | 2004 | 2631 | 0.220 |
Why?
|
Maxillofacial Abnormalities | 2 | 2014 | 22 | 0.220 |
Why?
|
Myosins | 3 | 2021 | 403 | 0.220 |
Why?
|
Enhancer Elements, Genetic | 1 | 2010 | 1343 | 0.220 |
Why?
|
Transcription Factors | 11 | 2013 | 12069 | 0.220 |
Why?
|
Cloning, Molecular | 29 | 2001 | 4171 | 0.220 |
Why?
|
Uterus | 2 | 2009 | 651 | 0.220 |
Why?
|
Hybrid Cells | 19 | 1998 | 422 | 0.210 |
Why?
|
Craniofacial Abnormalities | 3 | 2012 | 316 | 0.210 |
Why?
|
Craniofacial Dysostosis | 2 | 2014 | 74 | 0.210 |
Why?
|
Homeodomain Proteins | 3 | 2010 | 2407 | 0.210 |
Why?
|
Azoospermia | 1 | 2022 | 28 | 0.210 |
Why?
|
Pregnancy | 24 | 2024 | 29548 | 0.210 |
Why?
|
Glycoproteins | 5 | 2008 | 2200 | 0.210 |
Why?
|
Chromosomes, Human, X | 3 | 2014 | 316 | 0.210 |
Why?
|
Microarray Analysis | 3 | 2021 | 749 | 0.200 |
Why?
|
Genetic Markers | 8 | 2016 | 2607 | 0.200 |
Why?
|
Chromosomes, Human, Pair 15 | 3 | 1999 | 365 | 0.200 |
Why?
|
Integrases | 1 | 2024 | 516 | 0.200 |
Why?
|
Cryosurgery | 1 | 2006 | 469 | 0.190 |
Why?
|
Nerve Tissue Proteins | 5 | 2018 | 4404 | 0.190 |
Why?
|
Conserved Sequence | 5 | 2000 | 1165 | 0.190 |
Why?
|
Sequence Homology, Amino Acid | 17 | 2012 | 2754 | 0.190 |
Why?
|
Sequence Alignment | 7 | 2014 | 2174 | 0.190 |
Why?
|
Cell Line | 21 | 2016 | 15638 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 3 | 2024 | 979 | 0.190 |
Why?
|
Uniparental Disomy | 1 | 2021 | 45 | 0.190 |
Why?
|
Dosage Compensation, Genetic | 3 | 2002 | 207 | 0.180 |
Why?
|
Growth Differentiation Factor 6 | 1 | 2020 | 8 | 0.180 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2020 | 216 | 0.180 |
Why?
|
Cluster Analysis | 4 | 2012 | 2691 | 0.180 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 4 | 2010 | 253 | 0.180 |
Why?
|
Vesicular Transport Proteins | 1 | 2023 | 374 | 0.180 |
Why?
|
Carrier Proteins | 9 | 2024 | 4939 | 0.180 |
Why?
|
Testis | 4 | 2022 | 792 | 0.180 |
Why?
|
Eye Abnormalities | 2 | 2014 | 242 | 0.180 |
Why?
|
Genome | 4 | 2024 | 1736 | 0.180 |
Why?
|
Oncogenes | 9 | 2003 | 1218 | 0.180 |
Why?
|
Photochemotherapy | 1 | 2006 | 807 | 0.180 |
Why?
|
Neoplasm Proteins | 8 | 2017 | 3606 | 0.180 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 17 | 0.180 |
Why?
|
Exons | 17 | 2013 | 2385 | 0.180 |
Why?
|
Auditory Pathways | 1 | 2002 | 237 | 0.170 |
Why?
|
DNA, Neoplasm | 10 | 2003 | 1746 | 0.170 |
Why?
|
Gene Expression Regulation | 11 | 2018 | 11881 | 0.170 |
Why?
|
Disease Models, Animal | 10 | 2019 | 18009 | 0.170 |
Why?
|
Transducin | 2 | 1996 | 42 | 0.170 |
Why?
|
Cerebellar Neoplasms | 1 | 2004 | 587 | 0.170 |
Why?
|
Streptococcal Vaccines | 1 | 2019 | 43 | 0.170 |
Why?
|
Menorrhagia | 1 | 2019 | 60 | 0.170 |
Why?
|
Chromosomes, Human, Pair 16 | 4 | 1998 | 343 | 0.160 |
Why?
|
Cell Adhesion Molecules | 3 | 2017 | 1600 | 0.160 |
Why?
|
Fertility | 1 | 2024 | 775 | 0.160 |
Why?
|
Middle Aged | 43 | 2024 | 218357 | 0.160 |
Why?
|
Hair Cells, Auditory | 3 | 2016 | 377 | 0.160 |
Why?
|
Nuclear Proteins | 3 | 2013 | 5787 | 0.160 |
Why?
|
Workflow | 2 | 2022 | 843 | 0.160 |
Why?
|
Ear Canal | 1 | 2019 | 146 | 0.160 |
Why?
|
Seizures | 2 | 2013 | 2897 | 0.160 |
Why?
|
Genetic Counseling | 3 | 2016 | 618 | 0.160 |
Why?
|
Phosphoproteins | 4 | 2014 | 2432 | 0.160 |
Why?
|
Tumor Cells, Cultured | 14 | 2003 | 6143 | 0.160 |
Why?
|
Cerebral Ventricles | 1 | 2001 | 539 | 0.160 |
Why?
|
Molecular Epidemiology | 1 | 2000 | 460 | 0.160 |
Why?
|
Genotype | 13 | 2014 | 12876 | 0.150 |
Why?
|
Tectorial Membrane | 1 | 1998 | 25 | 0.150 |
Why?
|
Gene Knock-In Techniques | 2 | 2010 | 416 | 0.150 |
Why?
|
Temporal Bone | 3 | 2016 | 683 | 0.150 |
Why?
|
Heterozygote | 5 | 2018 | 2787 | 0.150 |
Why?
|
Heart Defects, Congenital | 4 | 2012 | 4730 | 0.150 |
Why?
|
Human Genome Project | 5 | 2017 | 199 | 0.150 |
Why?
|
Family Health | 5 | 2010 | 1261 | 0.150 |
Why?
|
Chromosomes, Human, Pair 13 | 4 | 2004 | 195 | 0.150 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2002 | 1484 | 0.150 |
Why?
|
Pseudogenes | 4 | 2003 | 103 | 0.150 |
Why?
|
Myxoma | 3 | 2004 | 115 | 0.150 |
Why?
|
Retinitis Pigmentosa | 4 | 2004 | 395 | 0.140 |
Why?
|
Zebrafish | 8 | 2024 | 2983 | 0.140 |
Why?
|
Exostoses, Multiple Hereditary | 2 | 2014 | 29 | 0.140 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2018 | 144 | 0.140 |
Why?
|
Cadherins | 2 | 2018 | 897 | 0.140 |
Why?
|
DNA Copy Number Variations | 5 | 2023 | 2004 | 0.140 |
Why?
|
Choanal Atresia | 1 | 2017 | 40 | 0.140 |
Why?
|
Self Disclosure | 1 | 2018 | 250 | 0.140 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2012 | 599 | 0.140 |
Why?
|
Skin Neoplasms | 2 | 2015 | 5785 | 0.140 |
Why?
|
Molecular Biology | 1 | 2000 | 579 | 0.140 |
Why?
|
Microphthalmos | 1 | 2017 | 55 | 0.140 |
Why?
|
Sulfates | 1 | 1997 | 379 | 0.140 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2005 | 1065 | 0.140 |
Why?
|
Child, Preschool | 22 | 2021 | 41848 | 0.140 |
Why?
|
CapZ Actin Capping Protein | 1 | 2016 | 11 | 0.140 |
Why?
|
Germ Cells | 2 | 2018 | 633 | 0.130 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2016 | 90 | 0.130 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2016 | 43 | 0.130 |
Why?
|
Lod Score | 4 | 2012 | 603 | 0.130 |
Why?
|
Heterochromatin | 2 | 2013 | 292 | 0.130 |
Why?
|
Genetic Diseases, X-Linked | 2 | 2014 | 374 | 0.130 |
Why?
|
SOX9 Transcription Factor | 1 | 2016 | 145 | 0.130 |
Why?
|
Menopause | 1 | 2024 | 1639 | 0.130 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11312 | 0.130 |
Why?
|
Muscle Hypotonia | 2 | 2016 | 161 | 0.130 |
Why?
|
Synovitis, Pigmented Villonodular | 2 | 1992 | 32 | 0.130 |
Why?
|
Myosin Heavy Chains | 3 | 2004 | 400 | 0.130 |
Why?
|
Phospholipase D | 1 | 1995 | 67 | 0.130 |
Why?
|
Mice, Transgenic | 3 | 2024 | 9479 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 1 | 2003 | 1960 | 0.120 |
Why?
|
Embryo, Mammalian | 5 | 2010 | 1662 | 0.120 |
Why?
|
Auditory Threshold | 4 | 2010 | 370 | 0.120 |
Why?
|
RNA, Neoplasm | 4 | 2008 | 750 | 0.120 |
Why?
|
Mice, Knockout | 6 | 2018 | 14318 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3601 | 0.120 |
Why?
|
Microfilament Proteins | 3 | 2005 | 1132 | 0.120 |
Why?
|
Membrane Transport Proteins | 2 | 2017 | 1036 | 0.120 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2015 | 39 | 0.120 |
Why?
|
Spiral Ganglion | 1 | 2016 | 177 | 0.120 |
Why?
|
Pneumococcal Infections | 1 | 2019 | 498 | 0.120 |
Why?
|
Euchromatin | 2 | 2013 | 54 | 0.120 |
Why?
|
Cytoskeletal Proteins | 4 | 2013 | 1343 | 0.120 |
Why?
|
Symporters | 2 | 2012 | 359 | 0.120 |
Why?
|
Cochlear Duct | 2 | 2008 | 21 | 0.120 |
Why?
|
Telomerase | 1 | 2019 | 743 | 0.120 |
Why?
|
Muscular Dystrophies | 1 | 2017 | 387 | 0.120 |
Why?
|
Chromosomes, Human, Pair 4 | 4 | 2000 | 369 | 0.120 |
Why?
|
Loss of Heterozygosity | 3 | 2006 | 660 | 0.120 |
Why?
|
Child | 26 | 2021 | 79418 | 0.120 |
Why?
|
DNA Probes | 4 | 2006 | 547 | 0.120 |
Why?
|
Zanthoxylum | 1 | 2013 | 1 | 0.120 |
Why?
|
Haplotypes | 3 | 2017 | 2759 | 0.120 |
Why?
|
Mice, Inbred CBA | 3 | 2010 | 428 | 0.120 |
Why?
|
POU Domain Factors | 1 | 2014 | 46 | 0.120 |
Why?
|
Heart Neoplasms | 3 | 2004 | 362 | 0.120 |
Why?
|
Streptococcus pneumoniae | 1 | 2019 | 724 | 0.120 |
Why?
|
Ataxia Telangiectasia | 5 | 1996 | 107 | 0.120 |
Why?
|
Aneuploidy | 5 | 2006 | 551 | 0.120 |
Why?
|
Blindness | 2 | 2002 | 585 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 765 | 0.110 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2013 | 49 | 0.110 |
Why?
|
Potassium Channels | 1 | 2016 | 532 | 0.110 |
Why?
|
Morphogenesis | 2 | 2016 | 738 | 0.110 |
Why?
|
Ultrasonography, Prenatal | 3 | 2012 | 1744 | 0.110 |
Why?
|
Peripheral Vascular Diseases | 1 | 1997 | 516 | 0.110 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 567 | 0.110 |
Why?
|
Mice, Inbred C57BL | 13 | 2019 | 21780 | 0.110 |
Why?
|
Neural Crest | 1 | 2016 | 277 | 0.110 |
Why?
|
Facial Bones | 1 | 2014 | 205 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2002 | 1178 | 0.110 |
Why?
|
Sequence Homology, Nucleic Acid | 8 | 1997 | 1054 | 0.110 |
Why?
|
Branchial Region | 1 | 2013 | 35 | 0.110 |
Why?
|
Polymorphism, Single-Stranded Conformational | 7 | 2005 | 331 | 0.110 |
Why?
|
Osteogenesis Imperfecta | 1 | 1993 | 81 | 0.110 |
Why?
|
Linkage Disequilibrium | 3 | 2019 | 1990 | 0.110 |
Why?
|
Hearing Loss, Conductive | 1 | 2014 | 159 | 0.110 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2015 | 220 | 0.110 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2013 | 139 | 0.100 |
Why?
|
Genetics, Population | 2 | 2019 | 921 | 0.100 |
Why?
|
Histone Deacetylases | 2 | 2012 | 709 | 0.100 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2012 | 80 | 0.100 |
Why?
|
5' Untranslated Regions | 2 | 2016 | 255 | 0.100 |
Why?
|
Aortic Coarctation | 1 | 2015 | 285 | 0.100 |
Why?
|
Nucleolus Organizer Region | 2 | 1983 | 25 | 0.100 |
Why?
|
Angiotensin II | 1 | 1995 | 849 | 0.100 |
Why?
|
Genetic Diseases, Inborn | 3 | 2006 | 597 | 0.100 |
Why?
|
SOXD Transcription Factors | 1 | 2012 | 44 | 0.100 |
Why?
|
Psychomotor Disorders | 1 | 2013 | 149 | 0.100 |
Why?
|
Alternative Splicing | 5 | 2012 | 1092 | 0.100 |
Why?
|
Gene Transfer Techniques | 2 | 2024 | 1206 | 0.100 |
Why?
|
Glaucoma | 3 | 2007 | 1175 | 0.100 |
Why?
|
Connexins | 3 | 2017 | 351 | 0.100 |
Why?
|
Guidelines as Topic | 3 | 2016 | 1392 | 0.100 |
Why?
|
Pigmentation Disorders | 2 | 2004 | 106 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2007 | 2896 | 0.100 |
Why?
|
Chromosomes, Human, 4-5 | 3 | 1986 | 26 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 1522 | 0.100 |
Why?
|
Genes, Recessive | 9 | 2021 | 625 | 0.100 |
Why?
|
Leukemia, Myeloid | 3 | 2005 | 697 | 0.100 |
Why?
|
Eye Proteins | 3 | 2004 | 629 | 0.100 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2017 | 726 | 0.100 |
Why?
|
HLA Antigens | 4 | 1986 | 1355 | 0.100 |
Why?
|
Gene Knockdown Techniques | 2 | 2013 | 1614 | 0.090 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 121 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2018 | 2818 | 0.090 |
Why?
|
Twins | 3 | 1981 | 338 | 0.090 |
Why?
|
Twins, Monozygotic | 3 | 1983 | 465 | 0.090 |
Why?
|
Head | 2 | 2016 | 920 | 0.090 |
Why?
|
Tyrosine | 1 | 1995 | 1440 | 0.090 |
Why?
|
Adolescent | 19 | 2021 | 87297 | 0.090 |
Why?
|
Amides | 1 | 2013 | 451 | 0.090 |
Why?
|
Acidosis, Renal Tubular | 2 | 2002 | 50 | 0.090 |
Why?
|
Tissue Distribution | 6 | 2001 | 2287 | 0.090 |
Why?
|
Proton-Translocating ATPases | 2 | 2002 | 113 | 0.090 |
Why?
|
Genes, myc | 3 | 2002 | 395 | 0.090 |
Why?
|
Peritoneal Cavity | 1 | 2010 | 141 | 0.090 |
Why?
|
Genes, Lethal | 2 | 2007 | 225 | 0.090 |
Why?
|
Language Development Disorders | 1 | 2012 | 192 | 0.090 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2011 | 158 | 0.090 |
Why?
|
Plasmids | 3 | 2024 | 2276 | 0.090 |
Why?
|
Calcium-Binding Proteins | 2 | 2002 | 1063 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1595 | 0.090 |
Why?
|
Cleft Lip | 2 | 2006 | 503 | 0.090 |
Why?
|
Vestibular Function Tests | 2 | 2008 | 128 | 0.090 |
Why?
|
Polymorphism, Genetic | 7 | 1997 | 4284 | 0.090 |
Why?
|
Ion Channels | 3 | 2007 | 1043 | 0.090 |
Why?
|
Placenta | 3 | 1995 | 1693 | 0.090 |
Why?
|
Blotting, Western | 5 | 2007 | 5040 | 0.090 |
Why?
|
Genes, Neoplasm | 2 | 2004 | 371 | 0.090 |
Why?
|
Skull | 1 | 2014 | 815 | 0.090 |
Why?
|
Vestibular Evoked Myogenic Potentials | 1 | 2010 | 88 | 0.090 |
Why?
|
Protein Isoforms | 4 | 2013 | 1698 | 0.090 |
Why?
|
Trans-Activators | 4 | 2011 | 2855 | 0.090 |
Why?
|
Zebrafish Proteins | 2 | 2013 | 1000 | 0.090 |
Why?
|
Polymorphism, Restriction Fragment Length | 10 | 1995 | 760 | 0.080 |
Why?
|
Psychotria | 1 | 2009 | 1 | 0.080 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 2000 | 350 | 0.080 |
Why?
|
Maternal Age | 3 | 2006 | 804 | 0.080 |
Why?
|
Dinucleotide Repeats | 1 | 2009 | 29 | 0.080 |
Why?
|
Antigens, Surface | 3 | 1988 | 1608 | 0.080 |
Why?
|
Facial Asymmetry | 1 | 1990 | 172 | 0.080 |
Why?
|
Hamartoma | 1 | 1991 | 233 | 0.080 |
Why?
|
Contractile Proteins | 1 | 1990 | 240 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2011 | 991 | 0.080 |
Why?
|
Lymphocytes | 6 | 2012 | 2598 | 0.080 |
Why?
|
Microcephaly | 1 | 2013 | 422 | 0.080 |
Why?
|
Leiomyoma, Epithelioid | 1 | 2008 | 3 | 0.080 |
Why?
|
Transgenes | 2 | 2024 | 999 | 0.080 |
Why?
|
Protein Structure, Tertiary | 4 | 2012 | 3797 | 0.080 |
Why?
|
Disulfides | 2 | 2012 | 464 | 0.080 |
Why?
|
Culture Techniques | 2 | 2003 | 529 | 0.080 |
Why?
|
Haploidy | 2 | 2007 | 133 | 0.080 |
Why?
|
Infant | 16 | 2021 | 35828 | 0.080 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 1985 | 176 | 0.080 |
Why?
|
Body Dysmorphic Disorders | 1 | 2012 | 241 | 0.080 |
Why?
|
Receptors, Cell Surface | 2 | 2016 | 2820 | 0.080 |
Why?
|
Glycosylation | 3 | 2014 | 1089 | 0.080 |
Why?
|
Globins | 3 | 1993 | 403 | 0.080 |
Why?
|
Trabecular Meshwork | 2 | 2007 | 100 | 0.080 |
Why?
|
Autistic Disorder | 4 | 2016 | 1212 | 0.080 |
Why?
|
Acoustic Stimulation | 2 | 2010 | 1244 | 0.080 |
Why?
|
Major Histocompatibility Complex | 3 | 1987 | 913 | 0.080 |
Why?
|
Membrane Proteins | 7 | 2023 | 7825 | 0.080 |
Why?
|
Amniotic Fluid | 3 | 2001 | 378 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 5 | 1990 | 2521 | 0.070 |
Why?
|
Monosomy | 3 | 2001 | 52 | 0.070 |
Why?
|
Mice, Inbred Strains | 3 | 2007 | 1759 | 0.070 |
Why?
|
Gene Duplication | 3 | 2013 | 314 | 0.070 |
Why?
|
Chromosomes, Human, 1-3 | 2 | 1984 | 22 | 0.070 |
Why?
|
Mutagenesis, Insertional | 2 | 2024 | 651 | 0.070 |
Why?
|
NFI Transcription Factors | 1 | 2007 | 42 | 0.070 |
Why?
|
Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
Limb Deformities, Congenital | 3 | 2003 | 136 | 0.070 |
Why?
|
Ocular Physiological Phenomena | 1 | 2007 | 67 | 0.070 |
Why?
|
Pelvic Neoplasms | 1 | 1989 | 248 | 0.070 |
Why?
|
Sequence Tagged Sites | 3 | 2002 | 94 | 0.070 |
Why?
|
Research | 2 | 2009 | 1968 | 0.070 |
Why?
|
Microsatellite Repeats | 5 | 2005 | 787 | 0.070 |
Why?
|
Protein Sorting Signals | 2 | 2000 | 279 | 0.070 |
Why?
|
Fetal Diseases | 1 | 2012 | 912 | 0.070 |
Why?
|
Point Mutation | 5 | 2019 | 1595 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2706 | 0.070 |
Why?
|
Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4279 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1049 | 0.070 |
Why?
|
Gestational Age | 3 | 2006 | 3557 | 0.070 |
Why?
|
Chondrosarcoma | 1 | 1989 | 293 | 0.070 |
Why?
|
Protein Tyrosine Phosphatases | 3 | 2006 | 460 | 0.070 |
Why?
|
Age Factors | 4 | 2015 | 18372 | 0.070 |
Why?
|
SUMO-1 Protein | 1 | 2006 | 35 | 0.070 |
Why?
|
RNA 3' Polyadenylation Signals | 1 | 2006 | 9 | 0.070 |
Why?
|
Scalp Dermatoses | 1 | 2006 | 44 | 0.070 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2006 | 68 | 0.070 |
Why?
|
Urogenital Abnormalities | 2 | 2007 | 255 | 0.070 |
Why?
|
Aged | 19 | 2019 | 167585 | 0.070 |
Why?
|
Access to Information | 1 | 2009 | 318 | 0.070 |
Why?
|
Chromosomes, Human, 13-15 | 2 | 1985 | 49 | 0.070 |
Why?
|
Facial Dermatoses | 1 | 2006 | 86 | 0.070 |
Why?
|
Chromosomes, Human, Y | 1 | 2007 | 160 | 0.070 |
Why?
|
Aminolevulinic Acid | 1 | 2006 | 141 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1894 | 0.060 |
Why?
|
Restriction Mapping | 6 | 1991 | 852 | 0.060 |
Why?
|
Stria Vascularis | 2 | 2022 | 30 | 0.060 |
Why?
|
Herpesvirus 4, Human | 1 | 2011 | 1069 | 0.060 |
Why?
|
Phylogeny | 4 | 2009 | 2754 | 0.060 |
Why?
|
Acyltransferases | 1 | 2007 | 302 | 0.060 |
Why?
|
Insulin-Like Growth Factor II | 2 | 1990 | 268 | 0.060 |
Why?
|
Somatomedins | 1 | 1986 | 176 | 0.060 |
Why?
|
Interphase | 1 | 2005 | 229 | 0.060 |
Why?
|
Breast Neoplasms | 5 | 2022 | 20889 | 0.060 |
Why?
|
Signal Transduction | 6 | 2019 | 23254 | 0.060 |
Why?
|
Aging | 3 | 2015 | 8595 | 0.060 |
Why?
|
Risk Factors | 5 | 2024 | 73898 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2007 | 243 | 0.060 |
Why?
|
Cataract | 1 | 2011 | 832 | 0.060 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 747 | 0.060 |
Why?
|
Epidermal Growth Factor | 2 | 1998 | 693 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9259 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2007 | 1172 | 0.060 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2011 | 602 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12503 | 0.060 |
Why?
|
Esthetics | 1 | 2006 | 319 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2004 | 8917 | 0.060 |
Why?
|
United States | 6 | 2024 | 71909 | 0.060 |
Why?
|
Aspartate Aminotransferases | 1 | 2006 | 414 | 0.060 |
Why?
|
Trismus | 1 | 2004 | 32 | 0.060 |
Why?
|
Infarction | 1 | 2006 | 248 | 0.060 |
Why?
|
Aortic Valve | 1 | 2015 | 1992 | 0.060 |
Why?
|
Preimplantation Diagnosis | 1 | 2006 | 143 | 0.060 |
Why?
|
Ecosystem | 1 | 2009 | 482 | 0.060 |
Why?
|
Clone Cells | 5 | 2002 | 1652 | 0.060 |
Why?
|
DNA, Mitochondrial | 2 | 2017 | 849 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13215 | 0.060 |
Why?
|
Burkitt Lymphoma | 2 | 1984 | 332 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2015 | 58608 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2013 | 1883 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9626 | 0.060 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2005 | 255 | 0.060 |
Why?
|
Autoradiography | 2 | 1995 | 739 | 0.060 |
Why?
|
Viral Proteins | 1 | 2011 | 1802 | 0.060 |
Why?
|
Demography | 1 | 2009 | 1645 | 0.060 |
Why?
|
Embryo, Nonmammalian | 1 | 2007 | 900 | 0.060 |
Why?
|
Organ Specificity | 4 | 2002 | 1954 | 0.060 |
Why?
|
Arthrogryposis | 1 | 2004 | 68 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 2 | 1995 | 2410 | 0.060 |
Why?
|
Pharmacogenetics | 1 | 2008 | 676 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2022 | 20002 | 0.060 |
Why?
|
Histocompatibility Antigens Class II | 2 | 1987 | 1415 | 0.060 |
Why?
|
Fertilization in Vitro | 1 | 1991 | 1283 | 0.060 |
Why?
|
Alanine Transaminase | 1 | 2006 | 605 | 0.060 |
Why?
|
Coitus | 1 | 2024 | 132 | 0.060 |
Why?
|
RNA Splicing | 4 | 2021 | 911 | 0.060 |
Why?
|
Membrane Glycoproteins | 3 | 2000 | 3676 | 0.050 |
Why?
|
Self-Injurious Behavior | 1 | 2009 | 548 | 0.050 |
Why?
|
Urinary Tract | 1 | 2007 | 309 | 0.050 |
Why?
|
Acetyltransferases | 1 | 2004 | 231 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2016 | 16782 | 0.050 |
Why?
|
Chickens | 3 | 2000 | 856 | 0.050 |
Why?
|
Growth Disorders | 2 | 2004 | 626 | 0.050 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2007 | 438 | 0.050 |
Why?
|
Adenocarcinoma | 3 | 1991 | 6317 | 0.050 |
Why?
|
Uridine | 1 | 1983 | 142 | 0.050 |
Why?
|
Laboratories | 2 | 2016 | 460 | 0.050 |
Why?
|
Epidemiologic Studies | 1 | 2006 | 669 | 0.050 |
Why?
|
China | 2 | 2019 | 2343 | 0.050 |
Why?
|
Rad51 Recombinase | 1 | 2003 | 187 | 0.050 |
Why?
|
Body Height | 1 | 2009 | 1564 | 0.050 |
Why?
|
Photosensitizing Agents | 1 | 2006 | 608 | 0.050 |
Why?
|
RNA, Ribosomal | 1 | 1983 | 223 | 0.050 |
Why?
|
Sequence Analysis | 2 | 2005 | 238 | 0.050 |
Why?
|
Calcium Channels | 3 | 2000 | 621 | 0.050 |
Why?
|
Cell Differentiation | 3 | 2016 | 11439 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2004 | 310 | 0.050 |
Why?
|
Neuropeptides | 1 | 2008 | 940 | 0.050 |
Why?
|
Receptors, Complement | 2 | 1997 | 253 | 0.050 |
Why?
|
Pseudopseudohypoparathyroidism | 1 | 2001 | 8 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6244 | 0.050 |
Why?
|
DNA Ligases | 1 | 2001 | 82 | 0.050 |
Why?
|
Jews | 2 | 2021 | 359 | 0.050 |
Why?
|
RNA | 4 | 2004 | 2711 | 0.050 |
Why?
|
Prevalence | 2 | 2018 | 15599 | 0.050 |
Why?
|
Face | 2 | 2004 | 1016 | 0.050 |
Why?
|
Coffee | 1 | 2006 | 582 | 0.050 |
Why?
|
3T3 Cells | 1 | 2003 | 1085 | 0.050 |
Why?
|
Oculomotor Muscles | 1 | 2005 | 409 | 0.050 |
Why?
|
Chorionic Villi Sampling | 1 | 2001 | 35 | 0.050 |
Why?
|
Taste Threshold | 1 | 1981 | 7 | 0.050 |
Why?
|
Models, Genetic | 3 | 2009 | 3439 | 0.050 |
Why?
|
Lymphangioma, Cystic | 1 | 2001 | 34 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2015 | 3971 | 0.050 |
Why?
|
COS Cells | 1 | 2003 | 1132 | 0.050 |
Why?
|
Thrombospondins | 2 | 1999 | 193 | 0.050 |
Why?
|
Polycystic Kidney Diseases | 1 | 2002 | 133 | 0.050 |
Why?
|
Genomic Imprinting | 2 | 2003 | 330 | 0.050 |
Why?
|
Database Management Systems | 1 | 2022 | 258 | 0.050 |
Why?
|
Protein Biosynthesis | 4 | 2000 | 2116 | 0.050 |
Why?
|
Blastocyst | 1 | 2004 | 427 | 0.050 |
Why?
|
Lipomatosis, Multiple Symmetrical | 1 | 2000 | 8 | 0.050 |
Why?
|
Gene Targeting | 1 | 2024 | 838 | 0.050 |
Why?
|
Cartilage | 2 | 1994 | 807 | 0.050 |
Why?
|
Ions | 1 | 2001 | 262 | 0.050 |
Why?
|
Rana catesbeiana | 1 | 2000 | 85 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1646 | 0.040 |
Why?
|
Acute Disease | 2 | 2008 | 7229 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2007 | 1427 | 0.040 |
Why?
|
Cells, Cultured | 8 | 2019 | 18929 | 0.040 |
Why?
|
Catalase | 1 | 2000 | 214 | 0.040 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 2000 | 26 | 0.040 |
Why?
|
Twins, Dizygotic | 1 | 1981 | 236 | 0.040 |
Why?
|
Chemotactic Factors | 2 | 1991 | 194 | 0.040 |
Why?
|
Semen | 1 | 2022 | 346 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2000 | 2286 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1995 | 489 | 0.040 |
Why?
|
Hormones | 1 | 2024 | 871 | 0.040 |
Why?
|
Color | 1 | 2001 | 298 | 0.040 |
Why?
|
B-Lymphocytes | 2 | 2011 | 4707 | 0.040 |
Why?
|
Receptors, Androgen | 2 | 1997 | 1070 | 0.040 |
Why?
|
Taste | 1 | 1981 | 186 | 0.040 |
Why?
|
Sexual Partners | 1 | 2024 | 748 | 0.040 |
Why?
|
Transfection | 3 | 2003 | 5781 | 0.040 |
Why?
|
Neoplasms, Experimental | 1 | 2004 | 1229 | 0.040 |
Why?
|
Mice, Mutant Strains | 2 | 2016 | 1763 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15773 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2003 | 682 | 0.040 |
Why?
|
Guanine Nucleotide Dissociation Inhibitors | 1 | 1998 | 23 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 1988 | 1264 | 0.040 |
Why?
|
Vulvar Neoplasms | 1 | 2001 | 264 | 0.040 |
Why?
|
Aquaporins | 1 | 1999 | 174 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2004 | 786 | 0.040 |
Why?
|
Louisiana | 1 | 1998 | 105 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2022 | 1738 | 0.040 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2001 | 354 | 0.040 |
Why?
|
Staining and Labeling | 1 | 1983 | 1094 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2011 | 10382 | 0.040 |
Why?
|
Laparoscopy | 1 | 2010 | 2153 | 0.040 |
Why?
|
Fluorescence | 1 | 2001 | 749 | 0.040 |
Why?
|
Fibroblasts | 5 | 2007 | 4065 | 0.040 |
Why?
|
L-Aminoadipate-Semialdehyde Dehydrogenase | 1 | 1997 | 2 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2006 | 1791 | 0.040 |
Why?
|
Extracellular Matrix | 2 | 2007 | 1720 | 0.040 |
Why?
|
Suicide | 1 | 2009 | 1605 | 0.040 |
Why?
|
Prader-Willi Syndrome | 1 | 1999 | 75 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4481 | 0.040 |
Why?
|
Case-Control Studies | 6 | 2012 | 21917 | 0.040 |
Why?
|
Pregnancy Trimester, Second | 1 | 2001 | 735 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2007 | 1707 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 482 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 6906 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1986 | 1917 | 0.040 |
Why?
|
Gene Order | 2 | 2012 | 169 | 0.040 |
Why?
|
Birth Weight | 1 | 2006 | 2076 | 0.040 |
Why?
|
Meniere Disease | 1 | 1999 | 161 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 1998 | 169 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2011 | 4489 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1999 | 418 | 0.040 |
Why?
|
Chemotactic Factors, Eosinophil | 1 | 1997 | 40 | 0.040 |
Why?
|
Kidney | 5 | 2007 | 6997 | 0.040 |
Why?
|
Veins | 1 | 2002 | 765 | 0.040 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1997 | 69 | 0.040 |
Why?
|
Chorionic Gonadotropin | 1 | 1999 | 457 | 0.040 |
Why?
|
Incidence | 2 | 2006 | 21259 | 0.040 |
Why?
|
Rats | 6 | 2007 | 23564 | 0.040 |
Why?
|
Protein Precursors | 1 | 2001 | 1131 | 0.040 |
Why?
|
Aldehyde Dehydrogenase | 1 | 1997 | 145 | 0.040 |
Why?
|
Ploidies | 2 | 1995 | 275 | 0.040 |
Why?
|
Blotting, Southern | 4 | 2007 | 782 | 0.040 |
Why?
|
rho GTP-Binding Proteins | 1 | 1998 | 279 | 0.040 |
Why?
|
Mannose-Binding Lectin | 1 | 1998 | 146 | 0.040 |
Why?
|
Costa Rica | 1 | 1997 | 177 | 0.030 |
Why?
|
HMGA1a Protein | 1 | 1997 | 63 | 0.030 |
Why?
|
Telomere | 1 | 2003 | 924 | 0.030 |
Why?
|
Angelman Syndrome | 1 | 1999 | 140 | 0.030 |
Why?
|
Cohort Studies | 3 | 2021 | 41121 | 0.030 |
Why?
|
Retina | 4 | 2002 | 2628 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 1997 | 223 | 0.030 |
Why?
|
Liver Neoplasms | 2 | 2000 | 4296 | 0.030 |
Why?
|
Apraxias | 1 | 2016 | 59 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 2000 | 654 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 1999 | 465 | 0.030 |
Why?
|
Blood Vessels | 1 | 2002 | 1113 | 0.030 |
Why?
|
Metaphase | 4 | 1991 | 145 | 0.030 |
Why?
|
Cell Movement | 2 | 2011 | 5178 | 0.030 |
Why?
|
Endodeoxyribonucleases | 1 | 1997 | 164 | 0.030 |
Why?
|
Chemokines, CC | 1 | 1997 | 282 | 0.030 |
Why?
|
Avian Proteins | 1 | 1996 | 80 | 0.030 |
Why?
|
Mydriatics | 1 | 1996 | 64 | 0.030 |
Why?
|
Cathepsins | 1 | 1997 | 242 | 0.030 |
Why?
|
Pulse | 1 | 1996 | 218 | 0.030 |
Why?
|
Epilepsy | 1 | 2011 | 3253 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2002 | 796 | 0.030 |
Why?
|
Biological Transport | 2 | 1997 | 2072 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1995 | 781 | 0.030 |
Why?
|
Perilymph | 1 | 1995 | 49 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2006 | 1900 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2003 | 1000 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2013 | 5072 | 0.030 |
Why?
|
Heparin | 1 | 2003 | 1653 | 0.030 |
Why?
|
Receptors, Calcitonin | 1 | 1995 | 34 | 0.030 |
Why?
|
Micrognathism | 1 | 2016 | 62 | 0.030 |
Why?
|
Models, Anatomic | 1 | 1999 | 683 | 0.030 |
Why?
|
Rats, Inbred WKY | 1 | 1995 | 152 | 0.030 |
Why?
|
Rats, Inbred SHR | 1 | 1995 | 187 | 0.030 |
Why?
|
Pathology | 1 | 1998 | 263 | 0.030 |
Why?
|
Genistein | 1 | 1995 | 86 | 0.030 |
Why?
|
DNA Damage | 2 | 2002 | 2418 | 0.030 |
Why?
|
Vision Screening | 1 | 1996 | 69 | 0.030 |
Why?
|
Recombination, Genetic | 5 | 2002 | 1527 | 0.030 |
Why?
|
DNA Helicases | 1 | 2000 | 843 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2006 | 14654 | 0.030 |
Why?
|
Wnt Proteins | 2 | 2011 | 719 | 0.030 |
Why?
|
Chorionic Villi | 1 | 1995 | 53 | 0.030 |
Why?
|
Second Messenger Systems | 1 | 1995 | 201 | 0.030 |
Why?
|
Mesoderm | 3 | 1995 | 670 | 0.030 |
Why?
|
Avidin | 1 | 1994 | 43 | 0.030 |
Why?
|
Chorion | 1 | 1995 | 114 | 0.030 |
Why?
|
Specialty Boards | 1 | 2016 | 230 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1995 | 385 | 0.030 |
Why?
|
Isoflavones | 1 | 1995 | 136 | 0.030 |
Why?
|
Stem Cells | 2 | 2006 | 3525 | 0.030 |
Why?
|
Amino Acids, Dicarboxylic | 1 | 1994 | 23 | 0.030 |
Why?
|
Substrate Specificity | 2 | 1995 | 1790 | 0.030 |
Why?
|
Family | 1 | 2005 | 3188 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2024 | 2078 | 0.030 |
Why?
|
Amyloid | 1 | 2019 | 833 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2002 | 1086 | 0.030 |
Why?
|
Causality | 1 | 2000 | 1237 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2006 | 2227 | 0.030 |
Why?
|
Carcinogens, Environmental | 1 | 1994 | 72 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1347 | 0.030 |
Why?
|
Hair | 1 | 1997 | 491 | 0.030 |
Why?
|
Awards and Prizes | 1 | 1998 | 360 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1747 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2006 | 3443 | 0.030 |
Why?
|
Calcitonin | 1 | 1995 | 329 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7786 | 0.030 |
Why?
|
DNA Methylation | 2 | 1999 | 4323 | 0.030 |
Why?
|
Minisatellite Repeats | 1 | 1994 | 162 | 0.030 |
Why?
|
Biological Evolution | 4 | 1994 | 1067 | 0.030 |
Why?
|
Chromium | 1 | 1994 | 132 | 0.030 |
Why?
|
Amnion | 1 | 1995 | 198 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1989 | 4019 | 0.030 |
Why?
|
Biotin | 1 | 1994 | 253 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 888 | 0.030 |
Why?
|
Amidohydrolases | 1 | 1994 | 170 | 0.030 |
Why?
|
Amino Acid Oxidoreductases | 1 | 1994 | 149 | 0.030 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 1995 | 180 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 2 | 2005 | 209 | 0.030 |
Why?
|
CpG Islands | 2 | 2011 | 1208 | 0.030 |
Why?
|
Cell Adhesion | 2 | 2011 | 3091 | 0.030 |
Why?
|
Logistic Models | 1 | 2008 | 13316 | 0.030 |
Why?
|
DNA Repair | 1 | 2002 | 2022 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2019 | 1331 | 0.030 |
Why?
|
Young Adult | 3 | 2016 | 58143 | 0.030 |
Why?
|
Stereoisomerism | 1 | 2013 | 623 | 0.030 |
Why?
|
Suppression, Genetic | 1 | 2013 | 190 | 0.030 |
Why?
|
Breast | 1 | 2002 | 1977 | 0.030 |
Why?
|
Dermatitis, Allergic Contact | 1 | 1994 | 110 | 0.030 |
Why?
|
Interleukin-2 | 1 | 1999 | 1872 | 0.030 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 1992 | 44 | 0.030 |
Why?
|
Prognosis | 2 | 2019 | 29463 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4421 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2016 | 432 | 0.030 |
Why?
|
Oligonucleotide Probes | 2 | 1990 | 418 | 0.030 |
Why?
|
Artifacts | 1 | 2001 | 1896 | 0.030 |
Why?
|
Mental Disorders | 1 | 2012 | 6794 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 2 | 1999 | 2801 | 0.030 |
Why?
|
Xenopus laevis | 3 | 2000 | 961 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2001 | 1857 | 0.020 |
Why?
|
Thrombosis | 1 | 2006 | 3033 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2002 | 2899 | 0.020 |
Why?
|
Core Binding Factor alpha Subunits | 1 | 2011 | 25 | 0.020 |
Why?
|
Crosses, Genetic | 3 | 1999 | 747 | 0.020 |
Why?
|
Hawaii | 1 | 1991 | 99 | 0.020 |
Why?
|
DNA Restriction Enzymes | 3 | 1986 | 553 | 0.020 |
Why?
|
Electroencephalography | 1 | 2007 | 6147 | 0.020 |
Why?
|
Immunoglobulins | 2 | 1985 | 864 | 0.020 |
Why?
|
Retinopathy of Prematurity | 1 | 1996 | 430 | 0.020 |
Why?
|
Placental Hormones | 1 | 1990 | 13 | 0.020 |
Why?
|
DNA Breaks | 1 | 2011 | 47 | 0.020 |
Why?
|
Species Specificity | 3 | 2009 | 2409 | 0.020 |
Why?
|
Wilms Tumor | 1 | 1994 | 376 | 0.020 |
Why?
|
Proteomics | 1 | 2004 | 3761 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1999 | 1309 | 0.020 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2011 | 53 | 0.020 |
Why?
|
Muscle Proteins | 1 | 1996 | 1151 | 0.020 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 1994 | 281 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2023 | 64582 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 2016 | 527 | 0.020 |
Why?
|
RNA, Antisense | 1 | 1991 | 136 | 0.020 |
Why?
|
Protein Folding | 1 | 2014 | 859 | 0.020 |
Why?
|
Polyps | 1 | 1992 | 198 | 0.020 |
Why?
|
AMP Deaminase | 1 | 1990 | 5 | 0.020 |
Why?
|
Nucleotide Deaminases | 1 | 1990 | 11 | 0.020 |
Why?
|
Brain | 5 | 2000 | 26883 | 0.020 |
Why?
|
Neoplasms | 3 | 2016 | 21899 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2004 | 2327 | 0.020 |
Why?
|
Isoenzymes | 1 | 1995 | 1689 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2012 | 399 | 0.020 |
Why?
|
Collagen Type I | 1 | 1993 | 593 | 0.020 |
Why?
|
Cell Nucleus | 2 | 1999 | 2907 | 0.020 |
Why?
|
Homeostasis | 1 | 2001 | 3284 | 0.020 |
Why?
|
Sarcoma | 1 | 2001 | 1788 | 0.020 |
Why?
|
Sodium Channels | 1 | 2012 | 344 | 0.020 |
Why?
|
Up-Regulation | 1 | 1999 | 4116 | 0.020 |
Why?
|
Granulosa Cell Tumor | 1 | 1991 | 71 | 0.020 |
Why?
|
Eye | 1 | 1994 | 711 | 0.020 |
Why?
|
Vimentin | 1 | 1991 | 255 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2011 | 311 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 1995 | 853 | 0.020 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2011 | 251 | 0.020 |
Why?
|
Profilins | 1 | 1990 | 65 | 0.020 |
Why?
|
Ribonucleases | 1 | 1990 | 274 | 0.020 |
Why?
|
Ribonuclease, Pancreatic | 1 | 1990 | 150 | 0.020 |
Why?
|
Mitosis | 1 | 1995 | 1199 | 0.020 |
Why?
|
Ligands | 2 | 2013 | 3288 | 0.020 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2011 | 132 | 0.020 |
Why?
|
Physical Examination | 1 | 1996 | 1241 | 0.020 |
Why?
|
MicroRNAs | 1 | 2006 | 3774 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2019 | 3363 | 0.020 |
Why?
|
Lung Neoplasms | 3 | 1991 | 13221 | 0.020 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 1992 | 211 | 0.020 |
Why?
|
Oligopeptides | 1 | 1995 | 1186 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 2 | 1988 | 375 | 0.020 |
Why?
|
Keratins | 1 | 1991 | 497 | 0.020 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 1982 | 649 | 0.020 |
Why?
|
Prospective Studies | 3 | 2023 | 54040 | 0.020 |
Why?
|
Subcellular Fractions | 2 | 2002 | 531 | 0.020 |
Why?
|
Enzyme Activation | 1 | 1995 | 3600 | 0.020 |
Why?
|
Tropical Climate | 1 | 2009 | 35 | 0.020 |
Why?
|
Ependymoma | 1 | 1992 | 320 | 0.020 |
Why?
|
Central America | 1 | 2009 | 64 | 0.020 |
Why?
|
Amniocentesis | 2 | 2001 | 116 | 0.020 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 1990 | 162 | 0.020 |
Why?
|
Molecular Structure | 1 | 2013 | 1904 | 0.020 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1989 | 317 | 0.020 |
Why?
|
Pulmonary Surfactants | 1 | 1989 | 161 | 0.020 |
Why?
|
Muridae | 2 | 2001 | 56 | 0.020 |
Why?
|
Muscles | 2 | 1991 | 1580 | 0.020 |
Why?
|
Angiogenesis Inducing Agents | 1 | 1990 | 279 | 0.020 |
Why?
|
Open Reading Frames | 1 | 1992 | 813 | 0.020 |
Why?
|
Cricetinae | 4 | 2001 | 2422 | 0.020 |
Why?
|
South America | 1 | 2009 | 181 | 0.020 |
Why?
|
Nervous System | 1 | 2012 | 542 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2484 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5418 | 0.020 |
Why?
|
Promoter Regions, Genetic | 5 | 1999 | 5787 | 0.020 |
Why?
|
Ontario | 1 | 2009 | 400 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 1989 | 247 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 1998 | 1377 | 0.020 |
Why?
|
T-Lymphocytes | 5 | 1999 | 10059 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 1 | 1992 | 532 | 0.020 |
Why?
|
Chromosomes, Artificial, Yeast | 2 | 1998 | 113 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1514 | 0.020 |
Why?
|
Chromosomes, Human, 21-22 and Y | 2 | 1986 | 45 | 0.020 |
Why?
|
Osteoblasts | 1 | 1993 | 1137 | 0.020 |
Why?
|
Axons | 1 | 2016 | 1668 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2610 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 1992 | 1058 | 0.020 |
Why?
|
Rhabdomyosarcoma | 1 | 1991 | 359 | 0.020 |
Why?
|
Hypertension | 1 | 2008 | 8532 | 0.020 |
Why?
|
Nucleosomes | 1 | 2011 | 483 | 0.020 |
Why?
|
Tubulin | 1 | 2011 | 692 | 0.020 |
Why?
|
Genome, Viral | 1 | 2011 | 655 | 0.020 |
Why?
|
Gelsolin | 1 | 1988 | 189 | 0.020 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 1988 | 169 | 0.020 |
Why?
|
Calcium | 1 | 2000 | 5704 | 0.020 |
Why?
|
Reference Values | 1 | 1995 | 4919 | 0.020 |
Why?
|
Phosphorylation | 2 | 1995 | 8312 | 0.020 |
Why?
|
Neurilemmoma | 1 | 1992 | 524 | 0.020 |
Why?
|
Macrophage-1 Antigen | 1 | 1988 | 286 | 0.020 |
Why?
|
Recombinant Proteins | 3 | 2006 | 6533 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3339 | 0.020 |
Why?
|
Macular Degeneration | 1 | 1995 | 1003 | 0.020 |
Why?
|
Otoacoustic Emissions, Spontaneous | 1 | 2007 | 139 | 0.020 |
Why?
|
Lymphokines | 1 | 1990 | 929 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2012 | 1549 | 0.020 |
Why?
|
TRPP Cation Channels | 2 | 1998 | 177 | 0.020 |
Why?
|
Immunoglobulin J-Chains | 1 | 1986 | 26 | 0.020 |
Why?
|
Carcinoma, Small Cell | 1 | 1989 | 416 | 0.020 |
Why?
|
Aqueous Humor | 1 | 2007 | 154 | 0.020 |
Why?
|
Geography | 1 | 2009 | 660 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8402 | 0.020 |
Why?
|
Risk Assessment | 2 | 2006 | 23956 | 0.020 |
Why?
|
Databases, Factual | 1 | 2002 | 7943 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1990 | 923 | 0.020 |
Why?
|
Palate | 1 | 2006 | 123 | 0.020 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 1988 | 361 | 0.020 |
Why?
|
HLA-DR Antigens | 2 | 1986 | 629 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2012 | 1121 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1989 | 534 | 0.020 |
Why?
|
Cytoplasm | 2 | 2002 | 1522 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 1987 | 452 | 0.020 |
Why?
|
Mutant Chimeric Proteins | 1 | 2005 | 20 | 0.020 |
Why?
|
Mutagenesis | 2 | 2001 | 1229 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6362 | 0.020 |
Why?
|
Occupational Diseases | 1 | 1994 | 1484 | 0.020 |
Why?
|
Bone Marrow | 1 | 2016 | 2907 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 79746 | 0.020 |
Why?
|
Phosphoglycerate Kinase | 1 | 1985 | 67 | 0.020 |
Why?
|
Leukemia | 2 | 1985 | 1510 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1988 | 617 | 0.020 |
Why?
|
Microtubules | 1 | 2011 | 1073 | 0.020 |
Why?
|
Pregnancy Outcome | 2 | 1997 | 2869 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2012 | 877 | 0.020 |
Why?
|
Calcium Channels, L-Type | 1 | 2007 | 238 | 0.020 |
Why?
|
Leucine Zippers | 2 | 1996 | 116 | 0.020 |
Why?
|
Audiometry | 1 | 2005 | 253 | 0.020 |
Why?
|
Oocytes | 2 | 2000 | 1166 | 0.020 |
Why?
|
Research Personnel | 1 | 2009 | 580 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 9113 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 1995 | 3725 | 0.010 |
Why?
|
Cell Aggregation | 1 | 2004 | 239 | 0.010 |
Why?
|
Ureter | 1 | 2007 | 378 | 0.010 |
Why?
|
Macromolecular Substances | 3 | 1995 | 1432 | 0.010 |
Why?
|
Hodgkin Disease | 1 | 1992 | 1379 | 0.010 |
Why?
|
Peer Review, Research | 1 | 2007 | 341 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2864 | 0.010 |
Why?
|
Repressor Proteins | 1 | 1995 | 2972 | 0.010 |
Why?
|
Occupational Exposure | 1 | 1994 | 1801 | 0.010 |
Why?
|
Genetic Techniques | 1 | 1986 | 428 | 0.010 |
Why?
|
Mass Screening | 1 | 1999 | 5411 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 2004 | 612 | 0.010 |
Why?
|
Mitochondria | 1 | 2017 | 3575 | 0.010 |
Why?
|
Neoplasm Invasiveness | 2 | 2003 | 3608 | 0.010 |
Why?
|
Actins | 1 | 2011 | 2053 | 0.010 |
Why?
|
Drosophila | 1 | 2011 | 1493 | 0.010 |
Why?
|
Chromosome Fragility | 1 | 2003 | 16 | 0.010 |
Why?
|
Chromosome Fragile Sites | 1 | 2003 | 26 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 1989 | 1018 | 0.010 |
Why?
|
Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8014 | 0.010 |
Why?
|
Protein Phosphatase 2 | 2 | 1995 | 236 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1994 | 1627 | 0.010 |
Why?
|
Skin Diseases | 1 | 1992 | 1090 | 0.010 |
Why?
|
Centrosome | 1 | 2004 | 207 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2005 | 879 | 0.010 |
Why?
|
Thymus Gland | 2 | 1999 | 1220 | 0.010 |
Why?
|
Endometrial Neoplasms | 1 | 1992 | 1367 | 0.010 |
Why?
|
Age of Onset | 2 | 2001 | 3297 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39187 | 0.010 |
Why?
|
Epithelium | 2 | 2002 | 1609 | 0.010 |
Why?
|
Cesarean Section | 1 | 1991 | 1382 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1986 | 553 | 0.010 |
Why?
|
Genes, RAG-1 | 1 | 2002 | 67 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2006 | 822 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2015 | 3810 | 0.010 |
Why?
|
Histone Acetyltransferases | 1 | 2004 | 334 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2003 | 463 | 0.010 |
Why?
|
Homozygote | 2 | 1997 | 1783 | 0.010 |
Why?
|
Cell Division | 2 | 2003 | 4448 | 0.010 |
Why?
|
Mast Cells | 1 | 1989 | 1435 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2009 | 1497 | 0.010 |
Why?
|
Cytokines | 1 | 1997 | 7261 | 0.010 |
Why?
|
Plasmacytoma | 1 | 1982 | 171 | 0.010 |
Why?
|
Abnormalities, Severe Teratoid | 1 | 1981 | 5 | 0.010 |
Why?
|
Gene Dosage | 1 | 2006 | 1219 | 0.010 |
Why?
|
Soft Tissue Neoplasms | 1 | 1991 | 1153 | 0.010 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2001 | 85 | 0.010 |
Why?
|
Retroelements | 1 | 2003 | 162 | 0.010 |
Why?
|
Glycosaminoglycans | 1 | 2004 | 606 | 0.010 |
Why?
|
Radiation Hybrid Mapping | 1 | 2001 | 18 | 0.010 |
Why?
|
Quinacrine Mustard | 1 | 1981 | 2 | 0.010 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 1990 | 1274 | 0.010 |
Why?
|
Phenylthiourea | 1 | 1981 | 11 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1996 | 4909 | 0.010 |
Why?
|
Fingers | 1 | 2004 | 506 | 0.010 |
Why?
|
S100 Proteins | 1 | 2002 | 220 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2001 | 122 | 0.010 |
Why?
|
Caspase 3 | 1 | 2003 | 729 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1829 | 0.010 |
Why?
|
Williams Syndrome | 1 | 2003 | 194 | 0.010 |
Why?
|
Adenovirus E1A Proteins | 1 | 2000 | 73 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2009 | 2307 | 0.010 |
Why?
|
Skin | 1 | 1994 | 4443 | 0.010 |
Why?
|
Pregnancy, High-Risk | 1 | 2001 | 119 | 0.010 |
Why?
|
Anus, Imperforate | 1 | 1981 | 64 | 0.010 |
Why?
|
Cell Cycle | 2 | 1999 | 2932 | 0.010 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2001 | 246 | 0.010 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2004 | 588 | 0.010 |
Why?
|
Blood Pressure | 1 | 1996 | 8500 | 0.010 |
Why?
|
Brain Stem | 1 | 2005 | 857 | 0.010 |
Why?
|
Cattle | 2 | 1997 | 3845 | 0.010 |
Why?
|
Melanoma | 1 | 1999 | 5659 | 0.010 |
Why?
|
Caspases | 1 | 2003 | 878 | 0.010 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2001 | 256 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2001 | 573 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2000 | 328 | 0.010 |
Why?
|
Peptides | 1 | 1992 | 4321 | 0.010 |
Why?
|
Solar System | 1 | 1999 | 12 | 0.010 |
Why?
|
Consanguinity | 2 | 1997 | 453 | 0.010 |
Why?
|
Binomial Distribution | 1 | 1999 | 23 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2004 | 2669 | 0.010 |
Why?
|
Diabetes Insipidus | 1 | 1999 | 144 | 0.010 |
Why?
|
Scotland | 1 | 1999 | 142 | 0.010 |
Why?
|
TRPV Cation Channels | 1 | 2000 | 242 | 0.010 |
Why?
|
Origin Recognition Complex | 1 | 1998 | 20 | 0.010 |
Why?
|
Spinal Cord | 1 | 2007 | 1808 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 3398 | 0.010 |
Why?
|
Cosmids | 1 | 1998 | 105 | 0.010 |
Why?
|
Replication Origin | 1 | 1998 | 77 | 0.010 |
Why?
|
CHO Cells | 1 | 2001 | 1388 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2001 | 956 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 696 | 0.010 |
Why?
|
Transcription Factor Brn-3C | 1 | 1998 | 12 | 0.010 |
Why?
|
Binding Sites | 2 | 1997 | 6038 | 0.010 |
Why?
|
Puberty, Precocious | 1 | 1999 | 162 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3717 | 0.010 |
Why?
|
Mice, Nude | 1 | 2004 | 3588 | 0.010 |
Why?
|
Myocardium | 1 | 1990 | 4682 | 0.010 |
Why?
|
Chemokine CCL11 | 1 | 1997 | 128 | 0.010 |
Why?
|
Cathepsin K | 1 | 1997 | 65 | 0.010 |
Why?
|
HeLa Cells | 2 | 1999 | 3096 | 0.010 |
Why?
|
Seminiferous Tubules | 1 | 1996 | 25 | 0.010 |
Why?
|
Proline | 1 | 1999 | 456 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 10806 | 0.010 |
Why?
|
Structure-Activity Relationship | 2 | 1995 | 3087 | 0.010 |
Why?
|
Cyclopentolate | 1 | 1996 | 6 | 0.010 |
Why?
|
Laminin | 1 | 1998 | 404 | 0.010 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1997 | 100 | 0.010 |
Why?
|
Complement C1q | 1 | 1997 | 94 | 0.010 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 1996 | 8 | 0.010 |
Why?
|
Mice, SCID | 1 | 2001 | 2617 | 0.010 |
Why?
|
Alagille Syndrome | 1 | 1996 | 46 | 0.010 |
Why?
|
Pesticides | 1 | 1999 | 282 | 0.010 |
Why?
|
Procaine | 1 | 1996 | 60 | 0.010 |
Why?
|
Zinc Fingers | 1 | 1998 | 568 | 0.010 |
Why?
|
Xanthines | 1 | 1996 | 122 | 0.010 |
Why?
|
Poly A | 2 | 1988 | 182 | 0.010 |
Why?
|
Dual Specificity Phosphatase 2 | 1 | 1995 | 5 | 0.010 |
Why?
|
Israel | 1 | 1998 | 720 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 930 | 0.010 |
Why?
|
Phenylephrine | 1 | 1996 | 293 | 0.010 |
Why?
|
Chimera | 1 | 1996 | 450 | 0.010 |
Why?
|
Fushi Tarazu Transcription Factors | 1 | 1995 | 24 | 0.010 |
Why?
|
Giant Cell Tumors | 1 | 1995 | 90 | 0.010 |
Why?
|
Steroidogenic Factor 1 | 1 | 1995 | 45 | 0.010 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 1995 | 203 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 1996 | 378 | 0.010 |
Why?
|
Australia | 1 | 1999 | 1283 | 0.010 |
Why?
|
Liver | 1 | 1991 | 7475 | 0.010 |
Why?
|
Cell Lineage | 1 | 2004 | 2510 | 0.010 |
Why?
|
Serine | 1 | 1999 | 828 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1229 | 0.010 |
Why?
|
Biotinidase | 1 | 1994 | 17 | 0.010 |
Why?
|
Foot | 1 | 1999 | 573 | 0.010 |
Why?
|
Epithelial Cells | 2 | 2002 | 3668 | 0.010 |
Why?
|
Fibronectins | 1 | 1998 | 721 | 0.010 |
Why?
|
Amino Acid Transport System X-AG | 1 | 1994 | 39 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 1736 | 0.010 |
Why?
|
Genes, Wilms Tumor | 1 | 1994 | 92 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1981 | 2361 | 0.010 |
Why?
|
Patch Tests | 1 | 1994 | 56 | 0.010 |
Why?
|
MafK Transcription Factor | 1 | 1993 | 8 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1914 | 0.010 |
Why?
|
NF-E2 Transcription Factor | 1 | 1993 | 38 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1991 | 4876 | 0.010 |
Why?
|
NF-E2 Transcription Factor, p45 Subunit | 1 | 1993 | 53 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 1999 | 1114 | 0.010 |
Why?
|
Spine | 1 | 1981 | 1102 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1993 | 195 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1995 | 478 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1995 | 911 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1995 | 330 | 0.010 |
Why?
|
Psoriasis | 1 | 2002 | 935 | 0.010 |
Why?
|
Hand | 1 | 1999 | 893 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1994 | 366 | 0.010 |
Why?
|
Schizophrenia | 1 | 2012 | 6897 | 0.010 |
Why?
|
Growth Substances | 1 | 1995 | 764 | 0.010 |
Why?
|
Adrenal Insufficiency | 1 | 1995 | 192 | 0.010 |
Why?
|
Down Syndrome | 1 | 2001 | 883 | 0.010 |
Why?
|
Radiotherapy | 1 | 1999 | 1508 | 0.010 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 1992 | 74 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1999 | 3471 | 0.010 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1992 | 31 | 0.010 |
Why?
|
Kidney Neoplasms | 2 | 1986 | 4305 | 0.010 |
Why?
|
Amino Acid Transport Systems, Basic | 1 | 1992 | 33 | 0.010 |
Why?
|
Rodentia | 1 | 1994 | 260 | 0.010 |
Why?
|
Reed-Sternberg Cells | 1 | 1992 | 72 | 0.010 |
Why?
|
Genes, ras | 1 | 1995 | 655 | 0.010 |
Why?
|
Kinetics | 1 | 2000 | 6371 | 0.010 |
Why?
|
DNA Replication | 1 | 1998 | 1408 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 775 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1998 | 2315 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1986 | 3209 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8456 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1995 | 1455 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 1994 | 908 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 1997 | 983 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1995 | 12203 | 0.010 |
Why?
|
Spleen | 1 | 1996 | 2275 | 0.010 |
Why?
|
Diploidy | 1 | 1990 | 132 | 0.010 |
Why?
|
Flow Cytometry | 2 | 1991 | 5841 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8159 | 0.010 |
Why?
|
Models, Molecular | 1 | 2000 | 5413 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1989 | 168 | 0.010 |
Why?
|
Mannose-Binding Lectins | 1 | 1989 | 96 | 0.010 |
Why?
|
Complement Factor I | 1 | 1989 | 14 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 1996 | 971 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1995 | 1755 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1991 | 219 | 0.010 |
Why?
|
Genes, Synthetic | 1 | 1989 | 88 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 1991 | 596 | 0.000 |
Why?
|
Hematologic Neoplasms | 1 | 2000 | 1882 | 0.000 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1992 | 795 | 0.000 |
Why?
|
Immunoglobulin Joining Region | 1 | 1988 | 37 | 0.000 |
Why?
|
Receptors, IgE | 1 | 1989 | 381 | 0.000 |
Why?
|
Isoelectric Point | 1 | 1987 | 76 | 0.000 |
Why?
|
Protein Binding | 1 | 1999 | 9300 | 0.000 |
Why?
|
Interleukin-8 | 1 | 1990 | 701 | 0.000 |
Why?
|
Apoptosis | 1 | 2003 | 9445 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 39991 | 0.000 |
Why?
|
Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.000 |
Why?
|
Immunoglobulin Variable Region | 1 | 1988 | 419 | 0.000 |
Why?
|
Palatine Tonsil | 1 | 1987 | 192 | 0.000 |
Why?
|
Neoplastic Stem Cells | 1 | 1994 | 1340 | 0.000 |
Why?
|
HLA-DQ Antigens | 1 | 1986 | 208 | 0.000 |
Why?
|
Wounds and Injuries | 1 | 1999 | 2445 | 0.000 |
Why?
|
Cricetulus | 1 | 1988 | 815 | 0.000 |
Why?
|
Immunoglobulin Constant Regions | 1 | 1985 | 58 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1989 | 2014 | 0.000 |
Why?
|
Disease Progression | 1 | 2002 | 13432 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2006 | 25715 | 0.000 |
Why?
|
Molecular Weight | 1 | 1987 | 2182 | 0.000 |
Why?
|
Genes, MHC Class II | 1 | 1985 | 443 | 0.000 |
Why?
|
Hematopoiesis | 1 | 1993 | 2058 | 0.000 |
Why?
|
DNA, Recombinant | 1 | 1984 | 455 | 0.000 |
Why?
|
Antigen-Presenting Cells | 1 | 1987 | 944 | 0.000 |
Why?
|
Immunoglobulin alpha-Chains | 1 | 1982 | 8 | 0.000 |
Why?
|
Immunoglobulin E | 1 | 1989 | 1500 | 0.000 |
Why?
|
Immunoglobulin mu-Chains | 1 | 1982 | 62 | 0.000 |
Why?
|
Bone Neoplasms | 1 | 1995 | 2532 | 0.000 |
Why?
|
Smoking | 1 | 1999 | 9054 | 0.000 |
Why?
|
Polyploidy | 1 | 1981 | 117 | 0.000 |
Why?
|
Fertilization | 1 | 1981 | 198 | 0.000 |
Why?
|
Antigens, CD | 1 | 1990 | 3909 | 0.000 |
Why?
|
Meiosis | 1 | 1981 | 326 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 11607 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1989 | 4874 | 0.000 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1985 | 1757 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1987 | 6118 | 0.000 |
Why?
|
Algorithms | 1 | 1998 | 13940 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1986 | 4342 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1988 | 12950 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1999 | 36181 | 0.000 |
Why?
|